Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 4/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL276572 | 1.00 | SLC7A5 (0.55) | SLC7A5FOLH1NAALAD2CA2CAMK2A | |
| SCHEMBL29278381 | 0.98 | SLC7A5 (0.53) | SLC7A5FOLH1NAALAD2CA2CAMK2A | |
| SCHEMBL23610314 | 0.86 | SLC7A5 (0.51) | SLC7A5FOLH1NAALAD2CA2CAMK2A | |
| SCHEMBL23610302 | 0.86 | SLC7A5 (0.51) | SLC7A5FOLH1NAALAD2CA2CAMK2A | |
| SCHEMBL31092852 | 0.85 | CYP1A2 (0.55) | SLC7A5FOLH1NAALAD2 | |
| SCHEMBL2986794 | 0.83 | SLC7A5 (0.56) | SLC7A5FOLH1NAALAD2CA2CAMK2A | |
| SCHEMBL2542276 | 0.83 | SLC7A5 (0.56) | SLC7A5FOLH1NAALAD2CA2CAMK2A | |
| SCHEMBL6300612 | 0.83 | SLC7A5 (0.53) | SLC7A5FOLH1NAALAD2CA2CAMK2A | |
| SCHEMBL6300611 | 0.83 | SLC7A5 (0.53) | SLC7A5FOLH1NAALAD2CA2CAMK2A | |
| SCHEMBL38225 | 0.81 | SLC7A5 (0.55) | SLC7A5FOLH1CA2CAMK2AESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116574138-B | Dibromotyrosine-iridium complex and preparation method and application thereof | 广东医科大学 | 2024-01-26 | — | — | CN | claimed |
| CN-116574138-A | Dibromotyrosine-iridium complex and preparation method and application thereof | 广东医科大学 | 2023-08-11 | — | — | CN | claimed |
| CN-109988312-B | Polyamide acid ester, preparation method, negative polyimide composition and application | 深圳先进技术研究院 | 2023-04-11 | — | — | CN | claimed |
| CN-107523219-B | Chemical Mechanical Polishing (CMP) of cobalt-containing substrates | 弗萨姆材料美国有限责任公司 | 2020-12-29 | — | — | CN | claimed |
| US-10745589-B2 | Chemical mechanical polishing (CMP) of cobalt-containing substrate | VERSUM MATERIALS US, LLC (US) | 2020-08-18 | — | — | US | claimed |
| EP-3257910-B1 | CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION, METHOD AND SYSTEM FOR COBALT-CONTAINING SUBSTRATE | VERSUM MAT US LLC (US) | 2019-03-27 | — | — | EP | claimed |
| US-20170362466-A1 | Chemical Mechanical Polishing (CMP) of Cobalt-Containing substrate | VERSUM MATERIALS US, LLC (US) | 2017-12-21 | — | — | US | claimed |
| EP-3257910-A1 | CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION, METHOD AND SYSTEM FOR COBALT-CONTAINING SUBSTRATE | Versum Materials US, LLC (US) | 2017-12-20 | — | — | EP | claimed |
| CN-105873944-A | Pro-angiogenic peptides and peptide conjugates | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2016-08-17 | — | — | CN | claimed |
| EP-1856274-B1 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | CLEVELAND CLINIC FOUNDATION (US) | 2014-08-27 | — | — | EP | claimed |
| US-6841689-B2 | Process using catalyst comprising soluble polymer and polymino acid | STYLACATS LIMITED (GB) | 2005-01-11 | — | — | US | claimed |
| US-20040048739-A1 | Catalyst comprising soluble polymer and polymino acid | STYLACATS LIMITED (GB) | 2004-03-11 | — | — | US | claimed |
| US-20030207324-A1 | IMMUNOTHERAPY BY MODULATION OF ANTIGEN PRESENTATION | HUMPHREYS ROBERT E | 2003-11-06 | — | — | US | claimed |
| EP-1289974-A1 | CATALYST COMPRISING SOLUBLE POLYMER AND POLYAMINO ACID | Stylacats Ltd (GB) | 2003-03-12 | — | — | EP | claimed |
| US-20020048775-A1 | Diagnostic methods for asthma | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-04-25 | — | — | US | claimed |
| WO-2001094327-A1 | CATALYST COMPRISING SOLUBLE POLYMER AND POLYAMINO ACID | STYLACATS LIMITED (GB) | 2001-12-13 | — | — | WO | claimed |
| US-6306576-B1 | ANALYZING SAMPLE FOR 3-BROMOTYROSINE AND/OR 3,5-DIBROMOTYROSINE; ELEVATED LEVELS INDICATE DISEASE ASSOCIATED WITH ACTIVATED EOSINOPHILS | CLEVELAND CLINIC FOUNDATION | 2001-10-23 | — | — | US | claimed |
| US-5919639-A | INCUBATING MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II EXPRESSING ANTIGEN PRESENTING CELL WITH MAMMALIAN INVARIANT CHAIN PEPTIDE OF 4-16 AMINO ACIDS, A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II RESTRICTED ANTIGENIC PEPTIDE, AND A T CELL | UNIVERSITY OF MASSACHUSETTS (US) | 1999-07-06 | — | — | US | claimed |
| US-5756650-A | COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | claimed |
| WO-1997049430-A1 | IMMUNOTHERAPY BY MODULATION OF ANTIGEN PRESENTATION | ANTIGEN EXPRESS, INC. (US) | 1997-12-31 | — | — | WO | claimed |